Oncogenic mutant RAS activity is rescaled by the ERK/MAPK pathway
Taryn E. Gillies, Michael Pargett, Jillian M. Silva, Carolyn Teragawa, Frank P. McCormick, John G. Albeck
The paper quantifies ERK activity in RAS-mutant cells and finds that mutant KRAS isoforms produce similar ERK output ranges despite differing biochemical activity, due to pathway-level rescaling mechanisms.
Molecular Systems Biology · Oct 1, 2020Peer-reviewedSystems Biology